HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Lu Selected Research

selenocysteine- tRNA

12/2021[EEFSEC knockdown inhibits proliferation, migration and invasion of prostate cancer cells in vitro].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Lu Research Topics

Disease

40Neoplasms (Cancer)
06/2022 - 01/2000
17Infections
01/2020 - 04/2000
11Breast Neoplasms (Breast Cancer)
08/2019 - 06/2000
10Inflammation (Inflammations)
03/2018 - 05/2000
9Body Weight (Weight, Body)
05/2015 - 07/2000
7Neoplasm Metastasis (Metastasis)
05/2021 - 10/2009
6Carcinogenesis
01/2020 - 03/2000
6Hypoxia (Hypoxemia)
03/2016 - 05/2001
5Squamous Cell Carcinoma of Head and Neck
11/2021 - 03/2010
5Carcinoma (Carcinomatosis)
01/2018 - 02/2001
5Obesity
05/2015 - 05/2000
4Insulin Resistance
12/2016 - 05/2000
4Type 2 Diabetes Mellitus (MODY)
10/2015 - 04/2005
4Ischemia
02/2013 - 08/2000
4Brain Ischemia (Cerebral Ischemia)
02/2013 - 09/2000
4Fibrosis (Cirrhosis)
08/2001 - 07/2000
3Wounds and Injuries (Trauma)
01/2021 - 10/2001
3Pain (Aches)
08/2020 - 02/2010
3Glioma (Gliomas)
07/2020 - 06/2000
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2019 - 11/2014
3Necrosis
10/2018 - 09/2002
3Lymphatic Metastasis
01/2018 - 01/2010
3Pneumonia (Pneumonitis)
07/2015 - 06/2000
3Osteosarcoma (Osteogenic Sarcoma)
01/2014 - 02/2000
3Stroke (Strokes)
01/2014 - 09/2000
3Reperfusion Injury
02/2013 - 01/2012
3Melanoma (Melanoma, Malignant)
01/2013 - 02/2008
2Esophageal Squamous Cell Carcinoma
01/2022 - 10/2013
2Thrombosis (Thrombus)
01/2022 - 05/2018
2Hemorrhage
04/2021 - 09/2019
2Fever (Fevers)
12/2020 - 01/2001
2Anemia
10/2020 - 01/2019
2Congenital Abnormalities (Deformity)
08/2020 - 10/2000
2Colorectal Neoplasms (Colorectal Cancer)
07/2019 - 01/2016
2Sepsis (Septicemia)
10/2018 - 04/2015
2Duodenal Ulcer (Curling's Ulcer)
07/2018 - 12/2001
2Myocardial Infarction
05/2018 - 12/2000
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2018 - 10/2000
2Macular Degeneration (Age-Related Maculopathy)
01/2018 - 08/2008
2Non-alcoholic Fatty Liver Disease
01/2018 - 01/2017
2Acute Kidney Injury (Acute Renal Failure)
09/2017 - 02/2016
2Ovarian Neoplasms (Ovarian Cancer)
01/2016 - 01/2014
2Cerebral Infarction
01/2015 - 01/2012

Drug/Important Bio-Agent (IBA)

25Proteins (Proteins, Gene)FDA Link
12/2021 - 02/2000
7Messenger RNA (mRNA)IBA
12/2021 - 02/2000
7CytokinesIBA
10/2018 - 07/2000
7Glucose (Dextrose)FDA LinkGeneric
01/2018 - 01/2000
6Biomarkers (Surrogate Marker)IBA
01/2021 - 10/2006
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2015 - 10/2000
5DNA (Deoxyribonucleic Acid)IBA
04/2019 - 06/2000
5Cisplatin (Platino)FDA LinkGeneric
06/2017 - 04/2009
5Insulin (Novolin)FDA Link
01/2016 - 01/2000
3Long Noncoding RNAIBA
06/2022 - 01/2018
3Indicators and Reagents (Reagents)IBA
11/2021 - 08/2015
3AntigensIBA
01/2019 - 01/2009
3Pharmaceutical PreparationsIBA
10/2017 - 02/2015
3CreatinineIBA
09/2017 - 12/2013
3VancomycinFDA LinkGeneric
09/2017 - 04/2015
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2016 - 12/2000
3Oxygen (Dioxygen)IBA
11/2015 - 10/2000
3EnzymesIBA
09/2015 - 05/2009
3Peptide Hydrolases (Proteases)FDA Link
07/2015 - 07/2000
3Monoclonal AntibodiesIBA
07/2015 - 11/2000
3LeptinIBA
05/2015 - 05/2000
3Bromodeoxyuridine (BrdU)IBA
01/2015 - 01/2012
3Laminin (Merosin)IBA
01/2015 - 07/2000
3Factor VIII (Coagulation Factor VIII)IBA
09/2014 - 01/2014
3Estrogens (Estrogen)FDA Link
02/2013 - 08/2000
3ElementsIBA
10/2012 - 02/2001
3CollagenIBA
09/2008 - 10/2000
3Tretinoin (Retinoic Acid)FDA LinkGeneric
02/2007 - 02/2000
3InterferonsIBA
02/2007 - 07/2000
3Small Interfering RNA (siRNA)IBA
02/2007 - 02/2005
3ApigeninIBA
09/2002 - 03/2000
3Furazolidone (Furoxone)FDA Link
04/2002 - 11/2000
2MicroRNAs (MicroRNA)IBA
05/2021 - 01/2017
2LipidsIBA
10/2020 - 01/2017
2CholesterolIBA
10/2020 - 01/2017
2IronIBA
10/2020 - 10/2007
2Thiamine (Aneurin)FDA Link
01/2019 - 09/2015
2Fluorescein (Funduscein)FDA LinkGeneric
01/2018 - 03/2000
2Fentanyl (Sublimaze)FDA LinkGeneric
05/2017 - 02/2010
2Triglycerides (Triacylglycerol)IBA
01/2017 - 01/2016
2Cadherins (E-Cadherin)IBA
01/2017 - 03/2015
2Protein Isoforms (Isoforms)IBA
11/2016 - 12/2006
2Transcription Factors (Transcription Factor)IBA
11/2016 - 12/2006
2AntioxidantsIBA
01/2016 - 10/2015
2CalciumIBA
08/2015 - 08/2000
2SurvivinIBA
01/2015 - 01/2010

Therapy/Procedure

14Therapeutics
01/2021 - 08/2000
4Radiotherapy
01/2012 - 05/2000
3Injections
01/2018 - 06/2000
3Drug Therapy (Chemotherapy)
06/2017 - 06/2000
3Subcutaneous Injections
11/2001 - 07/2000
2Neoadjuvant Therapy
01/2022 - 08/2016
2Length of Stay
04/2021 - 07/2010
2Arthroplasty
08/2020 - 01/2000
2Stents
05/2018 - 10/2013
2Transplantation
09/2015 - 04/2010
2Sutures (Suture)
01/2015 - 01/2014